Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech firms squeezed by economy and hungry giants
Boston Globe, MA
Saturday, November 6, 2010 - 1:38pm
tags:
biotech
Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Bradenton Herald, FL
Saturday, November 6, 2010 - 1:25pm
tags:
Prolia, osteoporosis, Amgen
US Healthcare Market to Shine in Coming Years
SBWwire
Saturday, November 6, 2010 - 1:17pm
tags:
healthcare market
Biotech Initiatives in Biopharma Space: Would Darwin Approve?
Bioworld
Saturday, November 6, 2010 - 1:16pm
tags:
biotech
Key Data Approaching for Lexicon's Mid-Stage Pipeline
Morningstar
Saturday, November 6, 2010 - 1:08pm
tags:
Lexicon Pharmaceuticals, LX2931, arthritis, LX1032, carcinoid syndrome, LX1031, irritable bowel syndrome
More On Quintiles’ Pharmaceutical Investments
Forbes
Saturday, November 6, 2010 - 1:04pm
tags:
Quintiles
Bristol-Myers, AztraZeneca Win U.S. Diabetes Approval
Bloomberg
Saturday, November 6, 2010 - 1:03pm
tags:
Bristol-Myers Squibb, AstraZeneca, Kombiglyze, diabetes
Pfizer Pill Leads Race to Dominate $12 Billion Arthritis Market
Bloomberg
Saturday, November 6, 2010 - 1:01pm
tags:
Pfizer, tasocitinib, arthritis
Is MannKind a Bad News Buy?
Motley Fool
Saturday, November 6, 2010 - 12:59pm
tags:
MannKind, inhaled insulin, Afrezza, diabetes
GlaxoSmithKline and XenoPort Respond to FDA on Horizant™ for RLS
Yahoo/BusinessWire
Saturday, November 6, 2010 - 12:57pm
tags:
GSK, XenoPort, Horizant, restless legs syndrome
Medicis Pharma skin products boost 3Q profit
Yahoo/AP
Saturday, November 6, 2010 - 12:55pm
tags:
Medicis, Solodyn, acne, Dysport, Restylane, wrinkle treatments
Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
Yahoo/PR NewsWire
Saturday, November 6, 2010 - 12:51pm
tags:
Medivation, MDV3100, prostate cancer, PREVAIL trial
Sequenom Shares Popped: What You Need to Know
Motley Fool
Saturday, November 6, 2010 - 12:50pm
tags:
Sequenom
Bad Medicine: When Doctors Tip Off Wall Street
TheStreet.com
Friday, November 5, 2010 - 12:19pm
tags:
hedge funds, hepatitis C
MAP reports 3Q loss on lack of revenue
Yahoo/AP
Friday, November 5, 2010 - 12:18pm
tags:
earnings, MAP Pharmaceuticals
Roche melanoma drug shows promise in study
Reuters
Friday, November 5, 2010 - 11:57am
tags:
Roche, melanoma
Is Pfizer the Perfect Stock?
Motley Fool
Friday, November 5, 2010 - 11:34am
tags:
Pfizer
Halozyme Therapeutics 3Q loss narrows on revenue
Yahoo/AP
Friday, November 5, 2010 - 11:33am
tags:
earnings, Halozyme
Genzyme starts 1st phase of layoffs with 392 cuts
Yahoo/AP
Friday, November 5, 2010 - 11:32am
tags:
Genzyme, layoffs
GSK chief was right about tough-to-copy Advair
Fierce Pharma
Friday, November 5, 2010 - 11:23am
tags:
GSK, Advair, Teva Pharmaceuticals, generics, Andrew Witty

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.